Market Overview:
The global gastritis treatment drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of gastritis, rising awareness about various treatment options for gastritis, and technological advancements in the field of gastroenterology. The global gastritis treatment drugs market is segmented on the basis of type into acid-blocking medicines, antibiotics, antacids, histamine blockers, and others. The acid-blocking medicines segment is expected to dominate the global gastritis treatment drugs market during the forecast period owing to their high usage for treating various types of Gastroesophageal Reflux Disease (GERD). The antibiotics segment is projected to grow at a higher CAGR than other segments during the forecast period due to increasing incidence of antibiotic-resistant bacteria strains globally.
Product Definition:
Gastritis Treatment Drugs are used to treat gastritis, a condition that occurs when the stomach lining becomes inflamed. Symptoms of gastritis include nausea, vomiting, abdominal pain, and loss of appetite. Gastritis Treatment Drugs may be prescribed in the form of over-the-counter medications or prescription medications.
Acid-Blocking Medicines:
Acid-blocking medicines are used to reduce stomach acid production. They work by neutralizing the acid that is produced in the stomach when food is taken into the body. This medicine can be used for treating conditions such as peptic ulcer disease, gastritis, and Zollinger-Ellison syndrome among others.
Antibiotics:
Antibiotics are drugs used to treat bacterial infections. Bacterial infection includes various types of infections such as pneumonia, ear infection, skin rash and swelling, urinary tract infection (UTI), sexually transmitted diseases like chlamydia and gonorrhea among others. UTI is the most common type of bacterial infection observed in women between the age group of 20-60 years.
Application Insights:
Based on application, the global gastritis treatment drugs market is segmented into hospitals, clinics and other healthcare facilities. Hospitals held the largest share in 2017 owing to factors such as high patient admissions due to conditions such as heart diseases, cancer and respiratory problems. In addition, hospitals are considered centers of excellence in gastroenterology which attracts patients from across the globe for diagnosis and treatment of various gastrointestinal disorders.
The clinics segment is expected to witness lucrative growth over the forecast period owing to increasing demand for effective yet convenient treatments that do not require hospitalization or an overnight stay. Furthermore, a rise in travel & tourism has led to an increase in demand for Gastroenterology services resulting in higher penetration of these clinics worldwide.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high disease prevalence and availability of novel therapeutics. Rising preference for over-the-counter (OTC) medicines is also a major trend witnessed in this region. In addition, increasing awareness about gastritis treatment options and favorable reimbursement policies are some other factors contributing to regional growth.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising healthcare expenditure by governments as well as private organizations, improving infrastructure facilities in rural areas and rapid urbanization due to an increase in population density along with migration from developed regions such as North America & Europe towards emerging economies such as India & China for employment opportunities have increased significantly which has led rise incidence rate of chronic diseases including gastritis which will drive regional demand for treatment drugs over the forecast period.
Growth Factors:
- Increasing incidence of gastritis across the globe
- Rising awareness about the available treatment options for gastritis
- Growing demand for effective and safe drugs for the treatment of gastritis
- Technological advancements in drug development and delivery systems that offer better efficacy and safety profiles for gastritis drugs
- Availability of generic versions of branded drugs at affordable prices
Scope Of The Report
Report Attributes
Report Details
Report Title
Gastritis Treatment Drugs Market Research Report
By Type
Acid-Blocking Medicines, Antibiotics, Antacids, Histamine Blockers, Others
By Application
Hospitals, Clinics, Others
By Companies
Pfizer, AstraZeneca, Novartis, Cipla, Abbott Laboratories, Microbiotix, Reddy's Laboratories, Lupin Ltd, Perrigo Pharmaceutical, Sun Pharmaceutical Industries, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Gastritis Treatment Drugs Market Report Segments:
The global Gastritis Treatment Drugs market is segmented on the basis of:
Types
Acid-Blocking Medicines, Antibiotics, Antacids, Histamine Blockers, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- AstraZeneca
- Novartis
- Cipla
- Abbott Laboratories
- Microbiotix
- Reddy's Laboratories
- Lupin Ltd
- Perrigo Pharmaceutical
- Sun Pharmaceutical Industries
- Pfizer
Highlights of The Gastritis Treatment Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Acid-Blocking Medicines
- Antibiotics
- Antacids
- Histamine Blockers
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gastritis Treatment Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gastritis treatment drugs are medications used to treat gastritis. These medications can help relieve the symptoms of gastritis, such as pain, inflammation, and swelling. Some of the most common treatments for gastritis include antibiotics and antacids.
Some of the key players operating in the gastritis treatment drugs market are Pfizer, AstraZeneca, Novartis, Cipla, Abbott Laboratories, Microbiotix, Reddy's Laboratories, Lupin Ltd, Perrigo Pharmaceutical, Sun Pharmaceutical Industries, Pfizer.
The gastritis treatment drugs market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gastritis Treatment Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Gastritis Treatment Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Gastritis Treatment Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Gastritis Treatment Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Gastritis Treatment Drugs Market Size & Forecast, 2020-2028
4.5.1 Gastritis Treatment Drugs Market Size and Y-o-Y Growth
4.5.2 Gastritis Treatment Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Acid-Blocking Medicines
5.2.2 Antibiotics
5.2.3 Antacids
5.2.4 Histamine Blockers
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gastritis Treatment Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gastritis Treatment Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Acid-Blocking Medicines
9.6.2 Antibiotics
9.6.3 Antacids
9.6.4 Histamine Blockers
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Acid-Blocking Medicines
10.6.2 Antibiotics
10.6.3 Antacids
10.6.4 Histamine Blockers
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Acid-Blocking Medicines
11.6.2 Antibiotics
11.6.3 Antacids
11.6.4 Histamine Blockers
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Acid-Blocking Medicines
12.6.2 Antibiotics
12.6.3 Antacids
12.6.4 Histamine Blockers
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Acid-Blocking Medicines
13.6.2 Antibiotics
13.6.3 Antacids
13.6.4 Histamine Blockers
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gastritis Treatment Drugs Market: Competitive Dashboard
14.2 Global Gastritis Treatment Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 AstraZeneca
14.3.3 Novartis
14.3.4 Cipla
14.3.5 Abbott Laboratories
14.3.6 Microbiotix
14.3.7 Reddy's Laboratories
14.3.8 Lupin Ltd
14.3.9 Perrigo Pharmaceutical
14.3.10 Sun Pharmaceutical Industries
14.3.11 Pfizer
